Valérie Legrand

Title: Valérie Legrand: Innovator in Adenoviral Research

Introduction

Valérie Legrand is a prominent inventor based in Strasbourg, France. He has made significant contributions to the field of adenoviral research, holding 2 patents that focus on modified adenoviral fibers and their applications.

Latest Patents

Legrand's latest patents include "Modified adenoviral fibre and uses thereof" and "Modified adenoviral fiber and target adenoviruses." The first patent relates to a modified fiber of an adenovirus, which includes mutations in specific residues within the fiber structure. The second patent discusses an adenovirus fiber modified by mutations aimed at enhancing its interaction with natural cell receptors. This invention also encompasses a DNA fragment, an expression vector, and a cell line that expresses the modified fiber, along with its therapeutic applications and corresponding pharmaceutical compositions.

Career Highlights

Throughout his career, Valérie Legrand has focused on advancing the understanding and application of adenoviral technologies. His innovative work has the potential to impact various therapeutic areas, particularly in gene therapy and vaccine development.

Collaborations

Legrand has collaborated with notable colleagues, including Majid Mehtali and Pierre Boulanger, to further his research and development efforts in the field.

Conclusion

Valérie Legrand's contributions to adenoviral research exemplify the importance of innovation in biotechnology. His patents reflect a commitment to advancing medical science and improving therapeutic options for patients.